CD3-directed Antibody [EPC] class drugs

1 result
  • tzield - teplizumab - mzwv injection

    (Teplizumab-Mzwv)
    Provention Bio, Inc.
    TZIELD is indicated for delaying the onset of Stage 3 type 1 diabetes in adults and pediatric patients aged 8 years and older who have Stage 2 type 1 diabetes.